PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review

  • ID: 1291361
  • SWOT Analysis
  • 68 pages
  • GlobalData
  • PerkinElmer, Inc.
1 of 5

FEATURED COMPANIES

  • Beckman Coulter Inc
  • Bio-Rad Laboratories Inc
  • MilliporeSigma
  • Precipio Inc
  • Shimadzu Corp
  • Spectris plc
  • MORE
PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments and thermal analysis instruments, among others. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services, among others. Its products are used in various applications, including atomic spectroscopy, cell imaging and analysis, chromatography, DNA/RNA isolation, analysis and detection, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America, among others. PerkinElmer is headquartered in Waltham, Massachusetts, US.

PerkinElmer Inc Key Recent Developments

Apr 10, 2018: PerkinElmer Names James Mock as Chief Financial Officer
Apr 05, 2018: Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program
Feb 28, 2018: PerkinElmer Signals Translational Contributes to Pre-Clinical and Clinical Data Analysis at the Frederick National Laboratory for Cancer Research
Jan 29, 2018: PerkinElmer Launches CE-IVD Assay Kit to Screen Newborns Affected by Duchenne Muscular Dystrophy
Jan 25, 2018: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Beckman Coulter Inc
  • Bio-Rad Laboratories Inc
  • MilliporeSigma
  • Precipio Inc
  • Shimadzu Corp
  • Spectris plc
  • MORE
Section 1 - About the Company
  • PerkinElmer Inc - Key Facts
  • PerkinElmer Inc - Key Employees
  • PerkinElmer Inc - Key Employee Biographies
  • PerkinElmer Inc - Major Products and Services
  • PerkinElmer Inc - History
  • PerkinElmer Inc - Company Statement
  • PerkinElmer Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • PerkinElmer Inc - Business Description
  • Business Segment: Diagnostics Segment
  • Overview
  • Performance
  • Business Segment: Discovery & Analytical Solutions
  • Overview
  • Performance
  • Geographical Segment: International
  • Target Markets
  • Performance
  • Geographical Segment: US
  • Performance
  • R&D Overview
  • PerkinElmer Inc - Corporate Strategy
  • PerkinElmer Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • PerkinElmer Inc - Strengths
  • PerkinElmer Inc - Weaknesses
  • PerkinElmer Inc - Opportunities
  • PerkinElmer Inc - Threats
  • PerkinElmer Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • PerkinElmer Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • PerkinElmer Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Apr 10, 2018: PerkinElmer Names James Mock as Chief Financial Officer
  • Apr 05, 2018: Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program
  • Feb 28, 2018: PerkinElmer Signals Translational Contributes to Pre-Clinical and Clinical Data Analysis at the Frederick National Laboratory for Cancer Research
  • Jan 29, 2018: PerkinElmer Launches CE-IVD Assay Kit to Screen Newborns Affected by Duchenne Muscular Dystrophy
  • Jan 25, 2018: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2017
  • Jan 22, 2018: PerkinElmer to Showcase Innovative Workflow Solutions at SLAS 2018
  • Nov 02, 2017: PerkinElmer Announces Financial Results for the Third Quarter of 2017
  • Oct 30, 2017: PerkinElmer Elects Pascale Witz to its Board of Directors
  • Sep 21, 2017: State Key Laboratory of Biochemical Engineering and PerkinElmer Open Joint Translational Medical Engineering Demonstration Laboratory in Beijing
  • Sep 15, 2017: PerkinElmer Announces Future Retirement of Andy Wilson, Chief Financial Officer
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • PerkinElmer Inc, Key Facts
  • PerkinElmer Inc, Key Employees
  • PerkinElmer Inc, Key Employee Biographies
  • PerkinElmer Inc, Major Products and Services
  • PerkinElmer Inc, History
  • PerkinElmer Inc, Other Locations
  • PerkinElmer Inc, Subsidiaries
  • PerkinElmer Inc, Joint Venture
  • PerkinElmer Inc, Key Competitors
  • PerkinElmer Inc, Ratios based on current share price
  • PerkinElmer Inc, Annual Ratios
  • PerkinElmer Inc, Annual Ratios
  • PerkinElmer Inc, Annual Ratios
  • PerkinElmer Inc, Interim Ratios
  • PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • PerkinElmer Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • PerkinElmer Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • PerkinElmer Inc, Performance Chart (2013-2017)
  • PerkinElmer Inc, Ratio Charts
  • PerkinElmer Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • PerkinElmer Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Thermo Fisher Scientific Inc
  • Spectris plc
  • Shimadzu Corp
  • Precipio Inc
  • MilliporeSigma
  • Bio-Rad Laboratories Inc
  • Beckman Coulter Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll